Get startedLog in
    Picture of China Resources Pharmaceutical logo

    3320 — China Resources Pharmaceutical News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareBalancedLarge CapContrarian
    All News

    Brief: China Resources Pharmaceutical Group Says For Q1 Jiangzhong Pharmaceutical Sees A Total Operating Income Of About RMB890 Mln

    Picture of China Resources Pharmaceutical logoChina Resources Pharmaceutical
    15/03/2022 24:51
    March 15 (Reuters) - China Resources Pharmaceutical Group
Ltd  3320.HK :
    * FOR Q1 JIANGZHONG PHARMACEUTICAL IS EXPECTED TO HAVE A
TOTAL
OPERATING INCOME OF ABOUT RMB890 MILLION
    * IN Q1 OF 2022 NET PROFIT ATTRIBUTABLE EXPECTED TO BE
APPROXIMATELY RMB180 MILLION FOR JIANGZHONG PHARMACEUTICAL

Further company coverage:  3320.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on China Resources Pharmaceutical

    See all news